The Interaction Between Spinal PDGFRβ and μ Opioid Receptor in the Activation of Microglia in Morphine-Tolerant Rats
Related Experiment Video
Updated: Dec 12, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Zheng Li1, Xiaoqian Jia1, Xiaoling Peng1
1Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Purpose:
Opioid tolerance remains a challenging problem, which limits prolonged drug usage in clinics. Previous studies have shown a fundamental role of platelet-derived growth factor receptor β submit (PDGFRβ) in morphine tolerance. The aim of this study was to investigate the mechanisms of spinal PDGFRβ activation in morphine tolerance.
Methods:
Rats were treated with morphine for 7 days and the effect of drug was evaluated by tail-flick latency test. By using Western blot and real-time PCR, the interaction between μ opioid receptor (MOR) and PDGFRβ in microglia activation, as well as related signaling pathways during morphine tolerance were investigated.
Results:
Chronic PDGFRβ agonist could induce microglia activation in spinal cord and decrease the analgesic effect of morphine. PDGFRβ inhibitor suppressed microglia activation during the development of morphine tolerance. Furthermore, antagonizing MOR could effectively inhibit the phosphorylations of PDGFRβ and JNK. Blocking PDGFRβ had no influence on JNK signaling, while JNK inhibitor could decrease the phosphorylation of PDGFRβ.
Conclusion:
These results provide direct evidence that repeatedly activating MOR by morphine could induce the transactivation of PDGFRβ via JNK MAPK in spinal cord, which leads to microglia activation during the development of morphine tolerance.
Insights
Morphine tolerance involves spinal platelet-derived growth factor receptor β (PDGFRβ) activation. Repeated morphine use activates PDGFRβ via JNK MAPK, leading to microglia activation and reduced pain relief.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Opioid tolerance limits clinical use of analgesics.
- Platelet-derived growth factor receptor β (PDGFRβ) plays a role in morphine tolerance.
Purpose of the Study:
- Investigate spinal PDGFRβ activation mechanisms in morphine tolerance.
- Elucidate the role of PDGFRβ in opioid-induced microglia activation.
Main Methods:
- Rats received daily morphine for 7 days, with analgesic effects assessed via tail-flick latency.
- Western blot and real-time PCR analyzed μ opioid receptor (MOR) and PDGFRβ interactions, microglia activation, and signaling pathways.
Main Results:
- PDGFRβ activation in the spinal cord induced microglia activation and reduced morphine's analgesic effect.
- PDGFRβ inhibition suppressed microglia activation during morphine tolerance development.
- Morphine's μ opioid receptor (MOR) antagonism inhibited PDGFRβ and JNK phosphorylation; JNK inhibition reduced PDGFRβ phosphorylation.
Conclusions:
- Repeated μ opioid receptor (MOR) activation by morphine induces PDGFRβ transactivation via JNK MAPK in the spinal cord.
- This PDGFRβ activation leads to microglia activation, contributing to morphine tolerance.
More Related Videos
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
07:05Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management